Healthcare Capital Corp Announces Feb. 15 Special Meeting Date For Proposed Business Combination With Alpha Tau Medical Ltd.

Special Meeting Scheduled for February 15, 2022

 

The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTS

 

NEW YORK, New York and JERUSALEM, Israel, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp (NASDAQ:HCCC, HCCCW, and HCCCU))) (“HCCC”) today announced that on January 12, 2022, the U.S. Securities and Exchange Commission (“SEC”) declared effective the Registration Statement on Form F-4 (as amended, the “Registration Statement”) filed by Alpha Tau Medical Ltd. (“Alpha Tau”), which includes a definitive proxy statement/prospectus in connection with HCCC’s special meeting of stockholders (the “Special Meeting”). At the Special Meeting, stockholders of HCCC will consider the previously announced proposed business combination (the “Business Combination”) with Alpha Tau, an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.

 

The declaration of effectiveness of the Registration Statement by the SEC and the filing of the definitive proxy statement is an important step in Alpha Tau becoming a publicly traded company, with the goal of being listed on the NASDAQ under the symbol “DRTS” at the close of the Business Combination.

 

HCCC will hold the Special Meeting at 10:00 AM Eastern Time on February 15, 2022, to approve, among other things, the proposed Business Combination. Stockholders of record at the close of business on January 13, 2022 (the “Record Date”) will be entitled to receive notice of and to vote at the Special Meeting. The Special Meeting will be held as a virtual meeting via live audio webcast at https://www.cstproxy.com/healthcarecapitalcorp/2022.

 

To register and receive access to the virtual meeting, registered stockholders and beneficial stockholders (those holding shares through a stock brokerage account or by a bank or other holder of record) will need to follow the instructions applicable to them provided in the proxy statement/prospectus included in the Registration Statement.

 

The proxy statement/prospectus is being mailed to the Company’s stockholders of record as of the close of business on the Record Date. Notice of the Special Meeting was mailed on or about January 18, 2022 to stockholders of record as of the Record Date.